• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补偿了氨基酸 N 端乙酰化途径中突变的小鼠。

compensates for in mice in the amino-terminal acetylation pathway.

机构信息

Department of Life Science and College of Natural Sciences, Ewha Womans University, Seoul, Republic of Korea.

Laboratory Animal Resource Center Korea ResearchInstitute of Bioscience and Biotechnology, Chungbuk, Republic of Korea.

出版信息

Elife. 2021 Aug 6;10:e65952. doi: 10.7554/eLife.65952.

DOI:10.7554/eLife.65952
PMID:34355692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8376253/
Abstract

Amino-terminal acetylation is catalyzed by a set of N-terminal acetyltransferases (NATs). The NatA complex (including X-linked Naa10 and Naa15) is the major acetyltransferase, with 40-50% of all mammalian proteins being potential substrates. However, the overall role of amino-terminal acetylation on a whole-organism level is poorly understood, particularly in mammals. Male mice lacking show no globally apparent in vivo amino-terminal acetylation impairment and do not exhibit complete embryonic lethality. Rather nulls display increased neonatal lethality, and the majority of surviving undersized mutants exhibit a combination of hydrocephaly, cardiac defects, homeotic anterior transformation, piebaldism, and urogenital anomalies. is a previously unannotated -like paralog with NAT activity that genetically compensates for . Mice deficient for have no apparent phenotype, whereas mice deficient for and display embryonic lethality. The discovery of adds to the currently known machinery involved in amino-terminal acetylation in mice.

摘要

N 端乙酰化是由一组 N 端乙酰转移酶(NATs)催化的。NatA 复合物(包括 X 连锁的 Naa10 和 Naa15)是主要的乙酰转移酶,所有哺乳动物蛋白中有 40-50%可能是其底物。然而,在整体生物体水平上,N 端乙酰化的总体作用还知之甚少,特别是在哺乳动物中。缺乏 的雄性小鼠在体内没有明显的整体 N 端乙酰化损伤,也没有表现出完全的胚胎致死性。相反, 缺失的新生鼠致死率增加,大多数幸存的体型过小的突变体表现出头颅积水、心脏缺陷、同源性前转化、斑驳病和泌尿生殖系统异常的综合症状。 是一个以前未注释的与 NAT 活性相关的类似物,它在遗传上补偿了 。缺乏 的小鼠没有明显的表型,而缺乏 和 的小鼠则表现出胚胎致死性。 的发现增加了目前已知的在小鼠中参与 N 端乙酰化的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/8cc5f9864bfb/elife-65952-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/af1172fa18fc/elife-65952-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/13e26399acd2/elife-65952-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/1264c3fd9620/elife-65952-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/d5c931e83013/elife-65952-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/5887d31e16ee/elife-65952-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/a3cb898d1be4/elife-65952-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/b5d2dd9cde40/elife-65952-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/6e9e445a3ba4/elife-65952-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/7b5cefbd1bc9/elife-65952-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/e60161b2e04d/elife-65952-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/1a97a45d1450/elife-65952-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/b9c3092fbd30/elife-65952-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/4618c04e7a9a/elife-65952-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/116047abaab9/elife-65952-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/dc8d6dd0199d/elife-65952-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/4ef469445b41/elife-65952-fig6-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/130b29e70695/elife-65952-fig6-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/d63be8c4223b/elife-65952-fig6-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/8cc5f9864bfb/elife-65952-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/af1172fa18fc/elife-65952-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/13e26399acd2/elife-65952-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/1264c3fd9620/elife-65952-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/d5c931e83013/elife-65952-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/5887d31e16ee/elife-65952-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/a3cb898d1be4/elife-65952-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/b5d2dd9cde40/elife-65952-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/6e9e445a3ba4/elife-65952-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/7b5cefbd1bc9/elife-65952-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/e60161b2e04d/elife-65952-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/1a97a45d1450/elife-65952-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/b9c3092fbd30/elife-65952-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/4618c04e7a9a/elife-65952-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/116047abaab9/elife-65952-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/dc8d6dd0199d/elife-65952-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/4ef469445b41/elife-65952-fig6-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/130b29e70695/elife-65952-fig6-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/d63be8c4223b/elife-65952-fig6-figsupp5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb7/8376253/8cc5f9864bfb/elife-65952-fig7.jpg

相似文献

1
compensates for in mice in the amino-terminal acetylation pathway.补偿了氨基酸 N 端乙酰化途径中突变的小鼠。
Elife. 2021 Aug 6;10:e65952. doi: 10.7554/eLife.65952.
2
Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.评估 Naa10 敲除小鼠中可能存在的母体效应致死和遗传背景效应。
PLoS One. 2024 May 7;19(5):e0301328. doi: 10.1371/journal.pone.0301328. eCollection 2024.
3
A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.在两名患有智力障碍和小头畸形的男孩中鉴定出一种具有受损乙酰转移酶活性的新型NAA10 p.(R83H)变体。
BMC Med Genet. 2019 Jun 7;20(1):101. doi: 10.1186/s12881-019-0803-1.
4
p.(D10G) and p.(L11R) Variants Hamper Formation of the NatA N-Terminal Acetyltransferase Complex.p.(D10G)和 p.(L11R) 变异会阻碍 NatA N 端乙酰转移酶复合物的形成。
Int J Mol Sci. 2020 Nov 26;21(23):8973. doi: 10.3390/ijms21238973.
5
A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.酿酒酵母模型揭示了奥格登综合征N-末端乙酰转移酶NAA10 Ser37Pro突变体在体内的功能损伤。
Mol Cell Proteomics. 2014 Aug;13(8):2031-41. doi: 10.1074/mcp.M113.035402. Epub 2014 Jan 9.
6
N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.N-α-乙酰转移酶 10(NAA10)在发育中的作用:NAA10 的作用。
Exp Mol Med. 2018 Jul 27;50(7):1-11. doi: 10.1038/s12276-018-0105-2.
7
Expanding the Phenotype Associated with NAA10-Related N-Terminal Acetylation Deficiency.扩展与NAA10相关的N端乙酰化缺陷相关的表型
Hum Mutat. 2016 Aug;37(8):755-64. doi: 10.1002/humu.23001. Epub 2016 May 4.
8
Evaluating possible maternal effect lethality and genetic background effects in knockout mice.评估基因敲除小鼠中可能存在的母体效应致死性和遗传背景效应。
bioRxiv. 2024 Jan 10:2023.04.27.538618. doi: 10.1101/2023.04.27.538618.
9
Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.利用酿酒酵母研究NAA15核糖体结合突变体的功能。
BMC Res Notes. 2018 Jun 22;11(1):404. doi: 10.1186/s13104-018-3513-4.
10
Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.NAA15 截断变异与智力障碍、自闭症谱系障碍和先天性异常的可变水平有关。
Am J Hum Genet. 2018 May 3;102(5):985-994. doi: 10.1016/j.ajhg.2018.03.004. Epub 2018 Apr 12.

引用本文的文献

1
NAA10 (N-Alpha-Acetyltransferase 10): A Multifunctional Regulator in Development, Disease, and Cancer.NAA10(N-α-乙酰基转移酶10):发育、疾病和癌症中的多功能调节因子。
Cells. 2025 Jun 7;14(12):863. doi: 10.3390/cells14120863.
2
Illuminating the impact of N-terminal acetylation: from protein to physiology.揭示N端乙酰化的影响:从蛋白质到生理学
Nat Commun. 2025 Jan 15;16(1):703. doi: 10.1038/s41467-025-55960-5.
3
NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis.

本文引用的文献

1
Mechanisms of Congenital Heart Disease Caused by NAA15 Haploinsufficiency.NAA15 杂合不足导致先天性心脏病的机制。
Circ Res. 2021 Apr 16;128(8):1156-1169. doi: 10.1161/CIRCRESAHA.120.316966. Epub 2021 Feb 9.
2
iNrich, Rapid and Robust Method to Enrich N-Terminal Proteome in a Highly Multiplexed Platform.一种在高度多重化平台中富集 N 端蛋白质组的快速、稳健方法。
Anal Chem. 2020 May 5;92(9):6462-6469. doi: 10.1021/acs.analchem.9b05653. Epub 2020 Apr 21.
3
Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10.
NSUN2乳酸化通过增强GCLC依赖性谷胱甘肽合成来驱动癌细胞对铁死亡的抗性。
Redox Biol. 2025 Feb;79:103479. doi: 10.1016/j.redox.2024.103479. Epub 2024 Dec 19.
4
A repository of Ogden syndrome patient derived iPSC lines and isogenic pairs by X-chromosome screening and genome-editing.通过X染色体筛选和基因组编辑建立的奥格登综合征患者来源的诱导多能干细胞系和同基因对库。
bioRxiv. 2024 Sep 28:2024.09.28.615067. doi: 10.1101/2024.09.28.615067.
5
Evaluating possible maternal effect lethality and genetic background effects in Naa10 knockout mice.评估 Naa10 敲除小鼠中可能存在的母体效应致死和遗传背景效应。
PLoS One. 2024 May 7;19(5):e0301328. doi: 10.1371/journal.pone.0301328. eCollection 2024.
6
Loss of N-terminal acetyltransferase A activity induces thermally unstable ribosomal proteins and increases their turnover in Saccharomyces cerevisiae.N-末端乙酰转移酶 A 活性丧失导致酿酒酵母中热不稳定核糖体蛋白的产生,并增加其周转率。
Nat Commun. 2023 Jul 27;14(1):4517. doi: 10.1038/s41467-023-40224-x.
7
Evaluating possible maternal effect lethality and genetic background effects in knockout mice.评估基因敲除小鼠中可能存在的母体效应致死性和遗传背景效应。
bioRxiv. 2024 Jan 10:2023.04.27.538618. doi: 10.1101/2023.04.27.538618.
8
Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.扩展 NAA10 相关神经发育综合征和 NAA15 相关神经发育综合征的表型谱。
Eur J Hum Genet. 2023 Jul;31(7):824-833. doi: 10.1038/s41431-023-01368-y. Epub 2023 May 2.
9
Phenotypic variability and gastrointestinal manifestations/interventions for growth in NAA10-related neurodevelopmental syndrome.NAA10 相关神经发育综合征的表型变异性及生长的胃肠道表现/干预措施。
Am J Med Genet A. 2023 May;191(5):1293-1300. doi: 10.1002/ajmg.a.63152. Epub 2023 Feb 21.
10
Charting the N-Terminal Acetylome: A Comprehensive Map of Human NatA Substrates.绘制N端乙酰化组图谱:人类NatA底物的综合图谱。
Int J Mol Sci. 2021 Oct 2;22(19):10692. doi: 10.3390/ijms221910692.
鉴定重组人 ARD1/NAA10 的赖氨酸乙酰转移酶活性。
Molecules. 2020 Jan 29;25(3):588. doi: 10.3390/molecules25030588.
4
Naa10p Inhibits Beige Adipocyte-Mediated Thermogenesis through N-α-acetylation of Pgc1α.Naa10p 通过 Pgc1α 的 N-α-乙酰化抑制米色脂肪细胞介导的产热。
Mol Cell. 2019 Nov 7;76(3):500-515.e8. doi: 10.1016/j.molcel.2019.07.026. Epub 2019 Aug 15.
5
Gene redundancy and gene compensation: An updated view.基因冗余与基因补偿:一个更新的视角。
J Genet Genomics. 2019 Jul 20;46(7):329-333. doi: 10.1016/j.jgg.2019.07.001. Epub 2019 Jul 19.
6
A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.在两名患有智力障碍和小头畸形的男孩中鉴定出一种具有受损乙酰转移酶活性的新型NAA10 p.(R83H)变体。
BMC Med Genet. 2019 Jun 7;20(1):101. doi: 10.1186/s12881-019-0803-1.
7
Phenotypic and biochemical analysis of an international cohort of individuals with variants in NAA10 and NAA15.NAA10 和 NAA15 变异个体的国际队列的表型和生化分析。
Hum Mol Genet. 2019 Sep 1;28(17):2900-2919. doi: 10.1093/hmg/ddz111.
8
Co-translational, Post-translational, and Non-catalytic Roles of N-Terminal Acetyltransferases.N-末端乙酰转移酶的共翻译、翻译后及非催化作用
Mol Cell. 2019 Mar 21;73(6):1097-1114. doi: 10.1016/j.molcel.2019.02.007. Epub 2019 Mar 13.
9
polyadenylation signal variants cause syndromic microphthalmia.多聚腺苷酸化信号变异导致综合征性小眼症。
J Med Genet. 2019 Jul;56(7):444-452. doi: 10.1136/jmedgenet-2018-105836. Epub 2019 Mar 6.
10
Spotlight on protein N-terminal acetylation.聚焦蛋白质 N 端乙酰化。
Exp Mol Med. 2018 Jul 27;50(7):1-13. doi: 10.1038/s12276-018-0116-z.